224 related articles for article (PubMed ID: 37020564)
21. Comparison of clinical, pathological and long-term renal outcomes of children with Henoch-Schonlein purpura nephritis and IgA nephropathy.
Torun Bayram M; Heybeli C; Yıldız G; Soylu A; Celik A; Sarioglu S; Kavukçu S
Int Urol Nephrol; 2022 Aug; 54(8):1925-1932. PubMed ID: 34846620
[TBL] [Abstract][Full Text] [Related]
22. Significance of urinary full-length megalin in patients with IgA nephropathy.
Seki T; Asanuma K; Asao R; Nonaka K; Sasaki Y; Oliva Trejo JA; Kurosawa H; Hirayama Y; Horikoshi S; Tomino Y; Saito A
PLoS One; 2014; 9(12):e114400. PubMed ID: 25502002
[TBL] [Abstract][Full Text] [Related]
23. CD4 (+)CD 25 (+)Treg cells and IgA nephropathy patients with tonsillectomy: a clinical and pathological study.
Huang H; Sun W; Liang Y; Peng Y; Long XD; Liu Z; Wen X; Jia M; Tian R; Bai C; Li C
Int Urol Nephrol; 2014 Dec; 46(12):2361-9. PubMed ID: 25281312
[TBL] [Abstract][Full Text] [Related]
24. Complement factor H variants are associated with microangiopathy lesions in IgA nephropathy.
Hou W; Shi S; Zhou X; Wang S; Cai Q; Chen P; Liu L; Zhu L; Lv J; Zhang H
Int Immunopharmacol; 2022 Nov; 112():109234. PubMed ID: 36113314
[TBL] [Abstract][Full Text] [Related]
25. Circulating complement factor H-related protein 5 levels contribute to development and progression of IgA nephropathy.
Zhu L; Guo WY; Shi SF; Liu LJ; Lv JC; Medjeral-Thomas NR; Lomax-Browne HJ; Pickering MC; Zhang H
Kidney Int; 2018 Jul; 94(1):150-158. PubMed ID: 29759419
[TBL] [Abstract][Full Text] [Related]
26. Complement components, proteolysis‑related, and cell communication‑related proteins detected in urine proteomics are associated with IgA nephropathy.
Mucha K; Bakun M; Jaźwiec R; Dadlez M; Florczak M; Bajor M; Gala K; Pączek L
Pol Arch Med Wewn; 2014; 124(7-8):380-6. PubMed ID: 24938435
[TBL] [Abstract][Full Text] [Related]
27. Does circulating erythropoietin reflect progression of IgA nephropathy? Comparison with urinary N-acetyl-beta-D-glucosaminidase.
Machiguchi T; Yoshida H; Yonemoto S; Minakata T; Nomura K; Muso E; Tamura T; Sasayama S
Nephrol Dial Transplant; 1999 Mar; 14(3):635-40. PubMed ID: 10193812
[TBL] [Abstract][Full Text] [Related]
28. Alternative Complement Pathway Is Activated and Associated with Galactose-Deficient IgA
Chiu YL; Lin WC; Shu KH; Fang YW; Chang FC; Chou YH; Wu CF; Chiang WC; Lin SL; Chen YM; Wu MS
Front Immunol; 2021; 12():638309. PubMed ID: 34177889
[TBL] [Abstract][Full Text] [Related]
29. Variants in Complement Factor H and Complement Factor H-Related Protein Genes, CFHR3 and CFHR1, Affect Complement Activation in IgA Nephropathy.
Zhu L; Zhai YL; Wang FM; Hou P; Lv JC; Xu DM; Shi SF; Liu LJ; Yu F; Zhao MH; Novak J; Gharavi AG; Zhang H
J Am Soc Nephrol; 2015 May; 26(5):1195-204. PubMed ID: 25205734
[TBL] [Abstract][Full Text] [Related]
30. Development and validation of a diagnostic nomogram to evaluate tubular atrophy/interstitial fibrosis of IgA nephropathy.
Gan Y; Cai Y; Li J; Wu J; Zhang R; Han Q; Li W; Yang Q
Int J Med Sci; 2024; 21(4):674-680. PubMed ID: 38464822
[No Abstract] [Full Text] [Related]
31. Expression profile of BAFF in peripheral blood from patients of IgA nephropathy: Correlation with clinical features and Streptococcus pyogenes infection.
Zheng N; Fan J; Wang B; Wang D; Feng P; Yang Q; Yu X
Mol Med Rep; 2017 Apr; 15(4):1925-1935. PubMed ID: 28260100
[TBL] [Abstract][Full Text] [Related]
32. Decreased Expression of Urinary Mammalian Target of Rapamycin mRNA Is Related to Chronic Renal Fibrosis in IgAN.
Cao Y; Wang Y; Liu Y; Zhu X; Zhang G; Wang S; Chen X; Liu D; Fu C
Dis Markers; 2019; 2019():2424751. PubMed ID: 31485275
[TBL] [Abstract][Full Text] [Related]
33. Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy.
Chen P; Shi SF; Qu Z; Zhao N; Xie XF; Lv JC; Liu LJ; Zhang H
Ren Fail; 2018 Nov; 40(1):213-218. PubMed ID: 29619862
[TBL] [Abstract][Full Text] [Related]
34. Urine podocyte mRNAs mark disease activity in IgA nephropathy.
Fukuda A; Sato Y; Iwakiri T; Komatsu H; Kikuchi M; Kitamura K; Wiggins RC; Fujimoto S
Nephrol Dial Transplant; 2015 Jul; 30(7):1140-50. PubMed ID: 25956757
[TBL] [Abstract][Full Text] [Related]
35. Serum BAFF is elevated in patients with IgA nephropathy and associated with clinical and histopathological features.
Xin G; Shi W; Xu LX; Su Y; Yan LJ; Li KS
J Nephrol; 2013; 26(4):683-90. PubMed ID: 23042433
[TBL] [Abstract][Full Text] [Related]
36. Glomerular abundance of complement proteins characterized by proteomic analysis of laser-captured microdissected glomeruli associates with progressive disease in IgA nephropathy.
Paunas TIF; Finne K; Leh S; Marti HP; Mollnes TE; Berven F; Vikse BE
Clin Proteomics; 2017; 14():30. PubMed ID: 28814945
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive analysis of aberrantly expressed profiles of mRNA and its relationship with serum galactose-deficient IgA1 level in IgA nephropathy.
Liu Y; Liu X; Jia J; Zheng J; Yan T
J Transl Med; 2019 Sep; 17(1):320. PubMed ID: 31547815
[TBL] [Abstract][Full Text] [Related]
38. Severe glomerular C3 deposition indicates severe renal lesions and a poor prognosis in patients with immunoglobulin A nephropathy.
Wu J; Hu Z; Wang Y; Hu D; Yang Q; Li Y; Dai W; Zhu F; Yang J; Wang M; Zhu H; Liu L; He X; Han M; Yao Y; Pei G; Zeng R; Xu G
Histopathology; 2021 May; 78(6):882-895. PubMed ID: 33336446
[TBL] [Abstract][Full Text] [Related]
39. DCR2, a Cellular Senescent Molecule, Is a Novel Marker for Assessing Tubulointerstitial Fibrosis in Patients with Immunoglobulin A Nephropathy.
Chen J; Hu W; Xiao F; Lin L; Chen K; Wang L; Wang X; He Y
Kidney Blood Press Res; 2019; 44(5):1063-1074. PubMed ID: 31487717
[TBL] [Abstract][Full Text] [Related]
40. Profiling and initial validation of urinary microRNAs as biomarkers in IgA nephropathy.
Wang N; Bu R; Duan Z; Zhang X; Chen P; Li Z; Wu J; Cai G; Chen X
PeerJ; 2015; 3():e990. PubMed ID: 26056621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
